drugset / Trial / NCT02736539

Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea

NCT02736539 ↗

Phase 3 Withdrawn Clasado Biosciences Ltd
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study is designed as a randomized double-blinded treatment trial among travelers' to geographical areas with moderate-severe rates of traveler's diarrhea. Travelers will be randomized to receive CBS 2004 or masked placebo to be taken daily while traveling. The test article or placebo will be taken starting 7 days prior to travel.

Timeline

Start
2017-04-15
Primary completion
2018-12-31
Completion
2019-02-28

Outcome

Outcome not reported

Stopped (Business): “Commercial strategy”

Drugs

EvaluationDrugModalityDoseRoute
Subject CBS 2004 Unknown — —

Indications